Transplantation with IL-2 And IFN-Alpha Activated Bone Marrow Cells Followed By IL-2 Therapy In Patients With Acute Leukemia.

Cancer Immunotherapy

"Transplantation with IL-2 And IFN-Alpha Activated Bone Marrow Cells Followed By IL-2 Therapy In Patients With Acute Leukemia." M.Z. Han, S.Z. Feng, C.W. Li, J.L. Han, R. Jiang, W.W. Yan and Z.C. Han. Institute of Hematology, Chinese Academy of Medical Sciences, Tianjin 300020, P.R. China.

According to an abstract submitted by the authors to the 40th Annual American Society of Hematology Meeting, held December 4-8, 1998, in Miami Beach, Florida, "The disadvantage after autologous bone marrow transplantation (AMBT) is the higher relapse risk due to residual tumor cells in the graft and lack of Graft-versus-Leukemia (GVL) effect in …